Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25,508 | $28,468 | $30,401 | $40,235 |
| Short-Term Investments | $97,460 | $113,897 | $135,562 | $145,193 |
| Receivables | $879 | $30 | $0 | $146 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,677 | $6,671 | $4,041 | $3,057 |
| Total Curr. Assets | $129,524 | $149,066 | $170,004 | $188,631 |
| Property Plant & Equip (Net) | $18,459 | $19,826 | $20,785 | $20,425 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $461 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $418 | $499 | $474 | $525 |
| Total NC Assets | $19,338 | $20,325 | $21,259 | $20,950 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $148,862 | $169,391 | $191,263 | $209,581 |
| Liabilities | – | – | – | – |
| Payables | $848 | $1,215 | $2,036 | $1,121 |
| Short-Term Debt | $3,172 | $3,642 | $3,720 | $3,740 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,099 | $5,911 | $6,448 | $7,392 |
| Total Curr. Liab. | $11,119 | $10,768 | $12,204 | $12,253 |
| LT Debt | $8,519 | $9,582 | $10,276 | $10,614 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $73 |
| Total NC Liab. | $8,519 | $9,582 | $10,276 | $10,687 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8,519 | $13,224 | $13,996 | $14,354 |
| Total Liabilities | $19,638 | $20,350 | $22,480 | $22,940 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$309,777 | -$288,249 | -$266,995 | -$246,684 |
| AOCI | $87 | $2 | $0 | -$129 |
| Other Equity | $438,911 | $437,285 | $435,775 | $433,451 |
| Total Equity | $129,224 | $149,041 | $168,783 | $186,641 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $148,862 | $169,391 | $191,263 | $209,581 |
| Net Debt | -$13,817 | -$15,244 | -$16,405 | -$25,881 |